Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc.(TRDA) | 4,425,784 | 4,425,784 | 0 | $62.71M | $63.07M | 34.64% | +$354.1K |
| Dyne Therapeutics, Inc.(DYN) | 3,451,303 | 1,561,496 | -1,889,807 | $97.98M | $55.11M | 30.26% | -$42.88M |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | $37.36M | $40.64M | 22.32% | +$3.29M |
| Werewolf Therapeutics, Inc.(HOWL) | 4,284,172 | 4,284,172 | 0 | $27.76M | $10.45M | 5.74% | -$17.31M |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | $10.56M | $7.40M | 4.06% | -$3.16M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,555,461 | 5,555,461 | 0 | $8.78M | $5.42M | 2.97% | -$3.36M |